510(k) K260133
K260133 is an FDA 510(k) premarket notification submitted by Odin Medical Limited for the device "CADDIE". The FDA issued a decision of Substantially Equivalent on Sep 12, 2026. The device falls under product code QNP (Gastrointesinal Lesion Software Detection System), a Class II device regulated under 21 CFR 876.1520. Odin Medical Limited has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 12, 2026
- Date Received
- Jan 16, 2026
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Gastrointesinal Lesion Software Detection System
- Device Class
- Class II
- Regulation Number
- 876.1520
- Review Panel
- GU
- Submission Type
A gastrointestinal lesion software detection system is a computer-assisted detection device used in conjunction with endoscopy for the detection of abnormal lesions in the gastrointestinal tract. This device with advanced software algorithms brings attention to images to aid in the detection of lesions. The device may contain hardware to support interfacing with an endoscope.